Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome

Arthritis and Rheumatism

Volumn 42, Issue 2, 1999, Pages 229-239

  Manoussakis, Menelaos N ^a   Dimitriou, Ioannis D ^a   Kapsogeorgou, Efstathia K ^a   Xanthou, Georgia ^a   Paikos, Spiros ^a   Polihronis, Maria ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SCHOOL CHILD; SJOEGREN SYNDROME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD80; CELL LINE; CHILD; EPITHELIAL CELLS; FEMALE; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; UP-REGULATION;

EID: 0033045115     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X     Document Type: Article

References (60)

1. Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren's syndrome: clinical and immunological aspects. Heidelberg: Springer-Verlag; 1987.
2. Fox RI, Theophilopoulos AN, Altman A. Production of inlerleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome: detection of reactive cells by using antibody directed to synthetic peptides of IL 2. J Immunol 1985;135:3109-15.
3. Moutsopoulos HM, Hooks JJ, Chan CC, Dalavanga YA, Skopouli FN, Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis 1986;45:677-83.
4. Brookes SM, Price EJ, Venables PJW, Maini RN. Interferon-gamma and epithelial cell activation in Sjögren's syndrome. Br J Rheumatol 1995;34:226-31.
5. Boumpa D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary glands tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 1995;34:326-33.
6. Lindahl G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression in T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1985;61:475-82.
7. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum 1986;29:1105-11.
8. Skopouli FN, Kousvelari EE, Mertz P, Jaffe ES, Fox PC, Moutsopoulos HM. C-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. J Rheumatol 1992;19:693-9.
9. Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM, Youinou P. Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J Clin Immunol 1992;12:259-65.
10. De Wilde PCM, Kater L, Bodeutsch C, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ. Aberrant expression pattern of the SS-B/La antigen in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:783-91.
11. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, et al. Identification of a-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997;276:604-7.
12. Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
13. Bretscher PA, Cohn M. A theory of self discrimination. Science 1970;169:1042-9.
14. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-80.
15. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
16. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-13.
17. Satyaraj E, Rath S, Bal V. Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction. J Immunol 1995;155: 4669-75.
18. Nickoloff BJ, Mitra RJ, Lee K, Turka LA, Green J, Thompson C, et al. Discordant expression of CD28 ligands, BB-1 and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol 1993;142:1029-40.
19. Fleming TE, Mirando WS, Trefzer U, Tubesing KA, Elmets CA, In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermis. J Invest Dermatol 1993;101:754-8.
20. Lohse AW, Knolle PA, Bilo K, Uhrig A, Waldmann C, Ibe M, et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996;110:1175-81.
21. Maher SE, Karmann K, Min W, Hughes CC, Pober JS, Bothwell AL. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells. J Immunol 1996;157:3838-44.
22. Hersey P, Si Z, Smith MJ, Thomas WD. Expression of the costimulatory molecule B7 on melanoma cells. Int J Cancer 1994;58:527-32.
23. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, et al. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int J Cancer 1995;62:259-65.
24. Li J, Yang Y, Inoue H, Mori M, Akiyoshi T. The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: its regulation by interferon gamma and interleukin-10. Cancer Immunol Immunother 1996;43:213-9.
25. Tatsumi T, Takehara T, Katayama K, Mochizuki K, Yamamoto M, Kanto T, et al. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology 1997;25:1108-14.
26. Augustin M, Dietrich A, Niedner R, Kapp A, Schöpf E, Ledbetter JA, et al. Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. J Invest Dermatol 1993;100:275-81.
27. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
28. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Chisholm DM, Waterhouse JP, Mason DK. Lymphocytic sialadenitis in the major and minor salivary glands: a correlation in postmortem subjects. J Clin Pathol 1970;23:690-4.
31. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984;25:383-90.
32. Sabatini LM, Allen-Hoffmann L, Warner TF, Azen EA. Serial cultivation of epithelial cells from human and macaque salivary glands. In Vitro Cell Dev Biol 1991;27A:939-48.
33. Selvakumar A, Mohanraj BK, Eddy RL, Shows TB, White PC, Dupont B. Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics 1992;36:175-8.
34. Azuma M, Ito D, Yagita H, Okumara K, Phillips JH, Lanier LL, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
35. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Fujimura T, et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:1376-84.
36. Gaspari AA, Jenkins MK, Katz SI. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific TH1 clones. J Immunol 1988;141:2216-20.
37. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-8.
38. Mantzinger P. Tolerance, dancer, and the extended family. Annu Rev Immunol 1994;12:991-1045.
39. Guerder S, Meyerhoff J, Flavell R. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1994;1:155-66.
40. Marelli-Berg FM, Hargreaves REG, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major histocompatibility complex class II-expressing endothelial cells induce allospecific non-responsiveness in naive T cells. J Exp Med 1996;183:1603-12.
41. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.
42. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A 1993;90:6586-90.
43. Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 1994;6:797-807.
44. Roth R, Nakamura T, Mamula MJ. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996;157:2924-31.
45. Finck UK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225-7.
46. Cross AH, Girard TJ, Giacoletto KS, Evans RJ, Keeling RM, Lin RF, et al. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J Clin Invest 1995;95:2783-9.
47. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray C, Nabavi N, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181:1145-55.
48. Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, et al. Transgenic mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc Natl Acad Sci U S A 1994;91:3137-41.
49. Harlan DM, Abe R, Lee KP, June CH. Potential roles of the B7 and CD28 receptors families in autoimmunity and immune evasion. Clin Immunol Immunopathol 1995;75:99-111.
50. Balsa A, Dixey J, Sansom DM, Maddison PJ, Hall ND. Differential expression of the costimulalory molecules B7.1 (CD80) and B7/2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol 1996;35:33-7.
51. Liu MF, Kohsaka H, Sakurai H, Azuma M, Okumura K, Saito I, et al. The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 1996;39:110-4.
52. Denfeld RW, Kind P, Sontheimer RD, Schöpf E, Simon JC. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum 1997;40:814-21.
53. Tandon N, Metcalfe RA, Barnett D, Weetman AP. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. OJM 1994;87:231-6.
54. Bloom S, Simmons D, Jewell DP. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1). ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Fxp Immunol 1995;101:157-63.
55. Leon MP, Kirby JA, Gibbs P, Burl AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 1995;22:591-5.
56. Sfikakis PP, Anagnostopoulos J, Karameris A, Stamatiadou A, Charalambopoulos D, Aroni K, et al. Expression of the CD80 (B7/BB1) T cell costimulatory molecule in the skin of patients with systemic sclerosis [abstract]. Arthritis Rheum 1994;37 Suppl 9:S265.
57. Garcia-Cozar FJ, Lopez-Beltran A, Molina IJ, Benito P, Pena J, Santamaria M. Aberrant expression of the B7/BB1 antigen on thyroid cells of Graves-Basedow disease (GB): induction of B7 in thyroid cells which are not autoimmune [abstract]. Immunologia 1996;12:32.
58. Sugiura T, Murakawa Y, Takeuchi H, Imaoka K, Kondo M, Kobayashi S. Expression of adhesion molecules in inflammatory myopathies [abstract]. Arthritis Rheum 1996;39 Suppl 9:S98.
59. Schmidt D, Goronzy JJ, Weyand CM. CD4+CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
60. - T cells. J Exp Med 1991;173:759-62.